Shah Capital Management Trimmed Its Mobile Telesystems Ojc (MBT) Position, Enanta Pharmaceuticals (ENTA) Had 1 Bulls

May 30, 2017 - By Darrin Black

Shah Capital Management decreased Mobile Telesystems Ojc (MBT) stake by 54.58% reported in 2016Q4 SEC filing. Shah Capital Management sold 155,558 shares as Mobile Telesystems Ojc (MBT)’s stock declined 10.26%. The Shah Capital Management holds 129,442 shares with $1.18 million value, down from 285,000 last quarter. Mobile Telesystems Ojc now has $8.59 billion valuation. The stock decreased 0.11% or $0.01 during the last trading session, reaching $9.14. About 1,400 shares traded. Mobil’nye Telesistemy PAO (ADR) (NYSE:MBT) has risen 4.98% since May 30, 2016 and is uptrending. It has underperformed by 11.72% the S&P500.

Among 4 analysts covering Enanta Pharmaceuticals Inc (NASDAQ:ENTA), 1 have Buy rating, 1 Sell and 2 Hold. Therefore 25% are positive. Enanta Pharmaceuticals Inc had 11 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Enanta Pharmaceuticals Inc (NASDAQ:ENTA) has “Mkt Outperform” rating given on Friday, October 23 by JMP Securities. As per Thursday, April 28, the company rating was downgraded by JMP Securities. TheStreet downgraded the shares of ENTA in report on Saturday, August 8 to “Buy” rating. The stock of Enanta Pharmaceuticals Inc (NASDAQ:ENTA) has “Underweight” rating given on Friday, October 23 by Barclays Capital. The stock has “Buy” rating by Zacks on Friday, August 7. On Tuesday, August 9 the stock rating was maintained by JP Morgan with “Overweight”. See Enanta Pharmaceuticals Inc (NASDAQ:ENTA) latest ratings:

Among 8 analysts covering Mobile TeleSystems (NYSE:MBT), 2 have Buy rating, 0 Sell and 6 Hold. Therefore 25% are positive. Mobile TeleSystems had 15 analyst reports since August 19, 2015 according to SRatingsIntel. The company was upgraded on Friday, October 21 by Raiffeisen Centrobank. The firm has “Outperform” rating given on Monday, June 20 by Credit Suisse. The firm has “Hold” rating by HSBC given on Thursday, March 24. Citigroup upgraded it to “Buy” rating and $9 target in Wednesday, August 19 report. The firm has “Neutral” rating given on Thursday, March 10 by Citigroup. The firm has “Hold” rating given on Friday, April 7 by Standpoint Research. The firm has “Hold” rating by Deutsche Bank given on Thursday, March 24. The firm has “Buy” rating by Citigroup given on Monday, November 21. The firm has “Equal Weight” rating given on Friday, May 5 by Morgan Stanley. The company was upgraded on Thursday, January 14 by Deutsche Bank.

Since January 4, 2017, it had 0 insider buys, and 1 insider sale for $488,505 activity. Shares for $488,505 were sold by Or Yat Sun on Wednesday, January 4.

Investors sentiment decreased to 1.47 in 2016 Q4. Its down 0.06, from 1.53 in 2016Q3. It dived, as 13 investors sold Enanta Pharmaceuticals Inc shares while 36 reduced holdings. 23 funds opened positions while 49 raised stakes. 12.65 million shares or 0.84% less from 12.75 million shares in 2016Q3 were reported. Pinebridge Investments Lp invested 0.02% of its portfolio in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Great Point Ptnrs Limited Com has 5.7% invested in Enanta Pharmaceuticals Inc (NASDAQ:ENTA) for 828,253 shares. Wellington Llp has 0% invested in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Strs Ohio reported 23,000 shares. Pnc Fincl Services Gp holds 0% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA) or 84,236 shares. Metropolitan Life Co Ny accumulated 11,660 shares. Tudor Et Al has 0.01% invested in Enanta Pharmaceuticals Inc (NASDAQ:ENTA) for 15,470 shares. The Massachusetts-based Rhumbline Advisers has invested 0% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). 11,925 are owned by Nationwide Fund. Dimensional Fund Ltd Partnership stated it has 179,824 shares or 0% of all its holdings. National Bank Of Montreal Can has invested 0% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Pacad holds 0.01% or 1,800 shares. Us Natl Bank De invested in 2,224 shares or 0% of the stock. Manufacturers Life Insurance The has invested 0% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Zurcher Kantonalbank (Zurich Cantonalbank) reported 235 shares or 0% of all its holdings.

The stock decreased 0.76% or $0.23 on May 26, reaching $30.13. About shares traded. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) has risen 40.91% since May 30, 2016 and is uptrending. It has outperformed by 24.21% the S&P500.